Psychopharmacology and Psychiatry Updates
Psychopharmacology Institute
Show overview
Psychopharmacology and Psychiatry Updates has been publishing since 2024, and across the 2 years since has built a catalogue of 115 episodes. That works out to roughly 25 hours of audio in total. Releases follow a weekly cadence.
Episodes typically run ten to twenty minutes — most land between 10 min and 14 min — and the run-time is fairly consistent across the catalogue. None of the episodes are flagged explicit by the publisher. It is catalogued as a EN-language Health & Fitness show.
The show is actively publishing — the most recent episode landed 1 weeks ago, with 36 episodes already out so far this year. The busiest year was 2025, with 73 episodes published. Published by Psychopharmacology Institute.
From the publisher
Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.
Latest Episodes
View all 115 episodesThe Clinician's Guide to Paliperidone & Risperidone LAIs
Antipsychotic Switching: Six Clinical Tips
Mastering Long-Acting Injectables: Aripiprazole & Olanzapine
Predicting Lithium Response in Bipolar Disorder
Preventing Relapse: The Role of LAIs in Schizophrenia
Could Lithium Play a Role in Preventing Alzheimer's Disease?
Managing ADHD in Pregnancy: Weighing Risk versus Risk
Ondansetron for Negative Symptoms of Schizophrenia
Managing SSRIs During Pregnancy: Myths vs. Evidence
Rethinking Haloperidol's Cardiac Risk
Bipolar Disorder, Lithium, and Pregnancy: What the Evidence Says
Clozapine Monitoring: New Guidelines for the Post-REMS Era
Prescribing Through Pregnancy: Dosing, Levels, and Relapse Risk
Bright Light Therapy for Bipolar Depression
Lithium: Managing Cosmetic and Sexual Side Effects
KarXT: A New Era in Antipsychotics?
In this episode, we explore KarXT, a newly FDA-approved antipsychotic with a groundbreaking cholinergic mechanism, through the lens of a single powerful metric: the Number Needed to Treat. Could an NNT of 5 change how you approach treatment-resistant schizophrenia? Faculty: Oliver Freudenreich, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.75 CMEs: Quick Take Vol. 80 How Effective Is KarXT (Xanomeline-Trospium) for Schizophrenia? NNT and NNH Explained
Lithium: GI and Weight Side Effect Management
In this episode, we explore how to keep your patients on lithium by getting ahead of two of its most common challenges — weight gain and gastrointestinal side effects. Dr. David Osser from Harvard Medical School shares practical, proactive strategies to anticipate, prevent, and manage these issues before they drive your patients away from a medication that could truly change their lives. Faculty: David Osser, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.5 CME: Lithium: How to Manage Dosage and Side Effects How to Mitigate Weight Gain and Gastrointestinal Side Effects of Lithium
Beyond Weight Loss: Can Semaglutide Treat Alcohol Use Disorder?
In this episode, we explore a surprising new contender in the fight against alcohol use disorder — semaglutide. Could the blockbuster weight-loss drug also curb heavy drinking? We examine the first randomized controlled trial testing this GLP-1 receptor agonist specifically for AUD. Faculty: David A. Gorelick, M.D., Ph.D., D.L.F.A.P.A., F.A.S.A.M. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.75 CMEs: Quick Take Vol. 79 Semaglutide for Alcohol Use Disorder: New RCT Data
Managing Lithium's Renal Risks: Evidence-Based Strategies
In this episode, we explore lithium's renal side effects with Dr. David Osser from Harvard Medical School. How can we keep patients safe while using this highly effective medication? Discover the real risk numbers, prevention strategies, and evidence-based monitoring approaches that protect kidney function long-term. Faculty: David Osser, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.5 CMEs: Lithium: How to Manage Dosage and Side Effects Managing Renal Side Effects of Lithium Therapy
Cariprazine for Bipolar Illness in the Elderly: What the Data Show
In this episode, we explore cariprazine's efficacy and safety in older adults with bipolar I disorder. Does age change how we should dose this medication? Discover evidence-based insights on treating both depression and mania in elderly patients, plus critical pearls on monitoring for akathisia. Faculty: Kristin Raj, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.75 CMEs: Quick Take Vol. 79 Cariprazine Dosing for Bipolar Disorder In Older Adults